Dataset Information

Investigating the effect of modifying the EEG cap lead configuration on the gradient artifact in simultaneous EEG-fMRI.

ABSTRACT: EEG data recorded during simultaneous fMRI are contaminated by large voltages generated by time-varying magnetic field gradients. Correction of the resulting gradient artifact (GA) generally involves low-pass filtering to attenuate the high-frequency voltage fluctuations of the GA, followed by subtraction of a GA template produced by averaging over repeats of the artifact waveforms. This average artifact subtraction (AAS) process relies on the EEG amplifier having a large enough dynamic range to characterize the artifact voltages and on invariance of the artifact waveform over repeated image acquisitions. Saturation of the amplifiers and changes in subject position can leave unwanted residual GA after AAS. Previous modeling work suggested that modifying the lead layout and the exit position of the cable bundle on the EEG cap could reduce the GA amplitude. Here, we used simulations and experiments to evaluate the effect of modifying the lead paths on the magnitude of the GA and on the residual artifact after AAS. The modeling work showed that for wire paths following great circles, the smallest overall GA occurs when the leads converge at electrode Cz. The performance of this new cap design was compared with a standard cap in experiments on a spherical agar phantom and human subjects. Using gradient pulses applied separately along the three Cartesian axes, we found that the GA due to the foot-head gradient was most significantly reduced relative to a standard cap for the phantom, whereas the anterior-posterior GA was most attenuated for human subjects. In addition, there was an overall 37% reduction in the RMS GA amplitude produced by a standard EPI sequence when comparing the two caps on the phantom. In contrast, the subjects showed an 11% increase in the average RMS of the GA. This work shows that the optimal design reduces the GA on a spherical phantom however; these gains are not translated to human subjects, probably due to the differences in geometry.

SUBMITTER: Mullinger KJ

PROVIDER: S-EPMC4114285 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Investigating the effect of modifying the EEG cap lead configuration on the gradient artifact in simultaneous EEG-fMRI.

Mullinger Karen J KJ Chowdhury Muhammad E H ME Bowtell Richard R

Frontiers in neuroscience 20140729

EEG data recorded during simultaneous fMRI are contaminated by large voltages generated by time-varying magnetic field gradients. Correction of the resulting gradient artifact (GA) generally involves low-pass filtering to attenuate the high-frequency voltage fluctuations of the GA, followed by subtraction of a GA template produced by averaging over repeats of the artifact waveforms. This average artifact subtraction (AAS) process relies on the EEG amplifier having a large enough dynamic range to ...[more]

PMID: 25120427

Similar Datasets

Project description:Simultaneous electroencephalography-functional MRI (EEG-fMRI) is a technique that combines temporal (largely from EEG) and spatial (largely from fMRI) indicators of brain dynamics. It is useful for understanding neuronal activity during many different event types, including spontaneous epileptic discharges, the activity of sleep stages, and activity evoked by external stimuli and decision-making tasks. However, EEG recorded during fMRI is subject to imaging, pulse, environment and motion artifact, causing noise many times greater than the neuronal signals of interest. Therefore, artifact removal methods are essential to ensure that artifacts are accurately removed, and EEG of interest is retained. This paper presents a systematic review of methods for artifact reduction in simultaneous EEG-fMRI from literature published since 1998, and an additional systematic review of EEG-fMRI studies published since 2016. The aim of the first review is to distill the literature into clear guidelines for use of simultaneous EEG-fMRI artifact reduction methods, and the aim of the second review is to determine the prevalence of artifact reduction method use in contemporary studies. We find that there are many published artifact reduction techniques available, including hardware, model based, and data-driven methods, but there are few studies published that adequately compare these methods. In contrast, recent EEG-fMRI studies show overwhelming use of just one or two artifact reduction methods based on literature published 15-20 years ago, with newer methods rarely gaining use outside the group that developed them. Surprisingly, almost 15% of EEG-fMRI studies published since 2016 fail to adequately describe the methods of artifact reduction utilized. We recommend minimum standards for reporting artifact reduction techniques in simultaneous EEG-fMRI studies and suggest that more needs to be done to make new artifact reduction techniques more accessible for the researchers and clinicians using simultaneous EEG-fMRI.

Project description:EEG data acquired in an MRI scanner are heavily contaminated by gradient artifacts that can significantly compromise signal quality. We developed two new methods based on independent component analysis (ICA) for reducing gradient artifacts from spiral in-out and echo-planar pulse sequences at 3 T, and compared our algorithms with four other commonly used methods: average artifact subtraction (Allen, P., Josephs, O., Turner, R., 2000. A method for removing imaging artifact from continuous EEG recorded during functional MRI. NeuroImage 12, 230-239.), principal component analysis (Niazy, R., Beckmann, C., Iannetti, G., Brady, J., Smith, S., 2005. Removal of FMRI environment artifacts from EEG data using optimal basis sets. NeuroImage 28, 720-737.), Taylor series ( Wan, X., Iwata, K., Riera, J., Kitamura, M., Kawashima, R., 2006. Artifact reduction for simultaneous EEG/fMRI recording: adaptive FIR reduction of imaging artifacts. Clin. Neurophysiol. 117, 681-692.) and a conventional temporal ICA algorithm. Models of gradient artifacts were derived from simulations as well as a water phantom and performance of each method was evaluated on datasets constructed using visual event-related potentials (ERPs) as well as resting EEG. Our new methods recovered ERPs and resting EEG below the beta band (<12.5 Hz) with high signal-to-noise ratio (SNR>4). Our algorithms outperformed all of these methods on resting EEG in the theta and alpha bands (SNR>4); however, for all methods, signal recovery was modest (SNR approximately 1) in the beta band and poor (SNR<0.3) in the gamma band and above. We found that the conventional ICA algorithm performed poorly with uniformly low SNR (<0.1). Taken together, our new ICA-based methods offer a more robust technique for gradient artifact reduction when scanning at 3 T using spiral in-out and echo-planar pulse sequences. We provide new insights into the strengths and weaknesses of each method using a unified subspace framework.

Project description:Objective.Simultaneous electroencephalography-functional magnetic resonance imaging (EEG-fMRI) recordings offer a high spatiotemporal resolution approach to study human brain and understand the underlying mechanisms mediating cognitive and behavioral processes. However, the high susceptibility of EEG to MRI-induced artifacts hinders a broad adaptation of this approach. More specifically, EEG data collected during fMRI acquisition are contaminated with MRI gradients and ballistocardiogram artifacts, in addition to artifacts of physiological origin. There have been several attempts for reducing these artifacts with manual and time-consuming pre-processing, which may result in biasing EEG data due to variations in selecting steps order, parameters, and classification of artifactual independent components. Thus, there is a strong urge to develop a fully automatic and comprehensive pipeline for reducing all major EEG artifacts. In this work, we introduced an open-access toolbox with a fully automatic pipeline for reducing artifacts from EEG data collected simultaneously with fMRI (refer to APPEAR).Approach.The pipeline integrates average template subtraction and independent component analysis to suppress both MRI-related and physiological artifacts. To validate our results, we tested APPEAR on EEG data recorded from healthy control subjects during resting-state (n= 48) and task-based (i.e. event-related-potentials (ERPs);n= 8) paradigms. The chosen gold standard is an expert manual review of the EEG database.Main results.We compared manually and automated corrected EEG data during resting-state using frequency analysis and continuous wavelet transformation and found no significant differences between the two corrections. A comparison between ERP data recorded during a so-called stop-signal task (e.g. amplitude measures and signal-to-noise ratio) also showed no differences between the manually and fully automatic fMRI-EEG-corrected data.Significance.APPEAR offers the first comprehensive open-source toolbox that can speed up advancement of EEG analysis and enhance replication by avoiding experimenters' preferences while allowing for processing large EEG-fMRI cohorts composed of hundreds of subjects with manageable researcher time and effort.

Project description:Background: Potentially curative epilepsy surgery can be offered if a single, discrete epileptogenic zone (EZ) can be identified. For individuals in whom there is no clear concordance between clinical localization, scalp EEG, and imaging data, intracranial EEG (icEEG) may be needed to confirm a predefined hypothesis regarding irritative zone (IZ), seizure onset zone (SOZ), and EZ prior to surgery. However, icEEG has limited spatial sampling and may fail to reveal the full extent of epileptogenic network if predefined hypothesis is not correct. Simultaneous icEEG-fMRI has been safely acquired in humans and allows exploration of neuronal activity at the whole-brain level related to interictal epileptiform discharges (IED) captured intracranially. Methods: We report icEEG-fMRI in eight patients with refractory focal epilepsy who had resective surgery and good postsurgical outcome. Surgical resection volume in seizure-free patients post-surgically reflects confirmed identification of the EZ. IEDs on icEEG were classified according to their topographic distribution and localization (Focal, Regional, Widespread, and Non-contiguous). We also divided IEDs by their location within the surgical resection volume [primary IZ (IZ1) IED] or outside [secondary IZ (IZ2) IED]. The distribution of fMRI blood oxygen level-dependent (BOLD) changes associated with individual IED classes were assessed over the whole brain using a general linear model. The concordance of resulting BOLD map was evaluated by comparing localization of BOLD clusters with surgical resection volume. Additionally, we compared the concordance of BOLD maps and presence of BOLD clusters in remote brain areas: precuneus, cuneus, cingulate, medial frontal, and thalamus for different IED classes. Results: A total of 38 different topographic IED classes were identified across the 8 patients: Focal (22) and non-focal (16, Regional = 9, Widespread = 2, Non-contiguous = 5). Twenty-nine IEDs originated from IZ1 and 9 from IZ2. All IED classes were associated with BOLD changes. BOLD maps were concordant with the surgical resection volume for 27/38 (71%) IED classes, showing statistical global maximum BOLD cluster or another cluster in the surgical resection volume. The concordance of BOLD maps with surgical resection volume was greater (p < 0.05) for non-focal (87.5%, 14/16) as compared to Focal (59%, 13/22) IED classes. Additionally, BOLD clusters in remote cortical and deep brain areas were present in 84% (32/38) of BOLD maps, more commonly (15/16; 93%) for non-focal IED-related BOLD maps. Conclusions: Simultaneous icEEG-fMRI can reveal BOLD changes at the whole-brain level for a wide range of IEDs on icEEG. BOLD clusters within surgical resection volume and remote brain areas were more commonly seen for non-focal IED classes, suggesting that a wider hemodynamic network is at play.

Project description:Rising life expectancies coupled with an increasing awareness of age-related cognitive decline have led to the unwarranted use of psychopharmaceuticals, including acetylcholinesterase inhibitors (AChEIs), by significant numbers of healthy older individuals. This trend has developed despite very limited data regarding the effectiveness of such drugs on non-clinical groups and recent work indicates that AChEIs can have negative cognitive effects in healthy populations. For the first time, we use a combination of EEG and simultaneous EEG/fMRI to examine the effects of a commonly prescribed AChEI (donepezil) on cognition in healthy older participants. The short- and long-term impact of donepezil was assessed using two double-blind, placebo-controlled trials. In both cases, we utilised cognitive (paired associates learning (CPAL)) and electrophysiological measures (resting EEG power) that have demonstrated high-sensitivity to age-related cognitive decline. Experiment 1 tested the effects of 5 mg/per day dosage on cognitive and EEG markers at 6-hour, 2-week and 4-week follow-ups. In experiment 2, the same markers were further scrutinised using simultaneous EEG/fMRI after a single 5 mg dose. Experiment 1 found significant negative effects of donepezil on CPAL and resting Alpha and Beta band power. Experiment 2 replicated these results and found additional drug-related increases in the Delta band. EEG/fMRI analyses revealed that these oscillatory differences were associated with activity differences in the left hippocampus (Delta), right frontal-parietal network (Alpha), and default-mode network (Beta). We demonstrate the utility of simple cognitive and EEG measures in evaluating drug responses after acute and chronic donepezil administration. The presentation of previously established markers of age-related cognitive decline indicates that AChEIs can impair cognitive function in healthy older individuals. To our knowledge this is the first study to identify the precise neuroanatomical origins of EEG drug markers using simultaneous EEG/fMRI. The results of this study may be useful for evaluating novel drugs for cognitive enhancement.

Dataset Information

Investigating the effect of modifying the EEG cap lead configuration on the gradient artifact in simultaneous EEG-fMRI.

Publications

Investigating the effect of modifying the EEG cap lead configuration on the gradient artifact in simultaneous EEG-fMRI.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets